UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	July 16, 2018

Accession Number:	0001213900-18-008700
Submission Type:	POS AM
CIK: 0001448431 Company Name: OptimizeRx Corp File Number: 333-225095